152 related articles for article (PubMed ID: 37195918)
21. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
Gachigua SG; Karuga R; Ngunjiri A; Jarrahian C; Coffey PS; Kilbourne-Brook M; Otiso L
Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
[TBL] [Abstract][Full Text] [Related]
22. Perspectives on contraceptive implant use in women living with HIV in Cape Town, South Africa: a qualitative study among primary healthcare providers and stakeholders.
Brown A; Harries J; Cooper D; Morroni C
BMC Public Health; 2019 Jul; 19(1):1003. PubMed ID: 31349786
[TBL] [Abstract][Full Text] [Related]
23. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
[No Abstract] [Full Text] [Related]
24. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
[TBL] [Abstract][Full Text] [Related]
25. Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.
Minnis AM; Montgomery ET; Napierala S; Browne EN; van der Straten A
J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S222-S229. PubMed ID: 31764258
[TBL] [Abstract][Full Text] [Related]
26. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
[TBL] [Abstract][Full Text] [Related]
27. Unmet need for family planning, contraceptive failure, and unintended pregnancy among HIV-infected and HIV-uninfected women in Zimbabwe.
McCoy SI; Buzdugan R; Ralph LJ; Mushavi A; Mahomva A; Hakobyan A; Watadzaushe C; Dirawo J; Cowan FM; Padian NS
PLoS One; 2014; 9(8):e105320. PubMed ID: 25144229
[TBL] [Abstract][Full Text] [Related]
28. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa.
Leslie J; Kiweewa F; Palanee-Phillips T; Bunge K; Mhlanga F; Kamira B; Baeten J; Katz A; Hillier S; Montgomery E;
BMC Womens Health; 2021 Apr; 21(1):175. PubMed ID: 33892693
[TBL] [Abstract][Full Text] [Related]
29. Health care providers' attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe.
Lanham M; Ridgeway K; Mireku M; Nhamo D; Pillay D; Murire M; Stankevitz K; Kyongo J; Mullick S;
BMC Health Serv Res; 2021 Oct; 21(1):1112. PubMed ID: 34663320
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.
Milali MP; Resar D; Kaftan D; Campbell J; Olowu A; Edwards D; Platais I; Kim HY; Jenkins S; Bershteyn A
Front Reprod Health; 2023; 5():1144217. PubMed ID: 37266447
[TBL] [Abstract][Full Text] [Related]
31. Toward an intravaginal device to detect risk of preterm labor: a user-centered design approach in Sub-Saharan Africa.
Smith E; Milford C; Ngure K; Newmann S; Thuo NB; Berrios S; Beksinska ME; Mugo N; Rand L
Reprod Health; 2022 Jul; 19(1):171. PubMed ID: 35907873
[TBL] [Abstract][Full Text] [Related]
32. Key programmatic and policy considerations for introducing multipurpose prevention (MPT) methods: reflections from healthcare providers and key stakeholders in South Africa.
Kutywayo A; Mataboge P; Mthimkhulu N; Martin CE; Muhwava LS; Mazibuko M; Makalela N; Kwatsha K; Butler V; Mullick S
Front Reprod Health; 2024; 6():1249750. PubMed ID: 38444890
[TBL] [Abstract][Full Text] [Related]
33. Reproductive awareness and recognition of unintended pregnancy: young women, key informants and health care providers perspectives in South Africa.
Somefun OD; Harries J; Constant D
Reprod Health; 2021 Oct; 18(1):211. PubMed ID: 34702283
[TBL] [Abstract][Full Text] [Related]
34. Preventing repeat adolescent pregnancies with early adoption of the contraceptive implant.
Stevens-Simon C; Kelly L; Singer D
Fam Plann Perspect; 1999; 31(2):88-93. PubMed ID: 10224547
[TBL] [Abstract][Full Text] [Related]
35. Acceptability of Implants for HIV Treatment in Young Children: Perspectives of Health Care Providers in Johannesburg, South Africa.
Scorgie F; Hawley I; Fairlie L; Pahad S; Mathebula F; Mohuba R; London SJ; Cottrell ML; Johnson LM; Montgomery ET
AIDS Patient Care STDS; 2022 Oct; 36(10):389-395. PubMed ID: 36286579
[TBL] [Abstract][Full Text] [Related]
36. Providers' Perceptions and Training Needs for Counseling Adolescents Undergoing Voluntary Medical Male Circumcision.
Tobian AAR; Dam KH; Van Lith LM; Hatzold K; Marcell AV; Mavhu W; Kahabuka C; Mahlasela L; Patel EU; Njeuhmeli E; Seifert Ahanda K; Ncube G; Lija G; Bonnecwe C; Kaufman MR
Clin Infect Dis; 2018 Apr; 66(suppl_3):S198-S204. PubMed ID: 29617772
[TBL] [Abstract][Full Text] [Related]
37. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
[TBL] [Abstract][Full Text] [Related]
38. "We are not the same": African women's view of multipurpose prevention products in the TRIO clinical study.
Shapley-Quinn MK; Manenzhe KN; Agot K; Minnis AM; van der Straten A
Int J Womens Health; 2019; 11():97-107. PubMed ID: 30799959
[TBL] [Abstract][Full Text] [Related]
39. Sexual Attitudes, Beliefs, Practices, and HIV Risk During Pregnancy and Post-delivery: A Qualitative Study in Malawi, South Africa, Uganda, and Zimbabwe.
Ryan JH; Young A; Musara P; Reddy K; Macagna N; Guma V; Seyama L; Piper J; van der Straten A;
AIDS Behav; 2022 Mar; 26(3):996-1005. PubMed ID: 34907478
[TBL] [Abstract][Full Text] [Related]
40. Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda.
Alhassan Y; Twimukye A; Malaba T; Orrell C; Myer L; Waitt C; Lamorde M; Kambugu A; Reynolds H; Khoo S; Taegtmeyer M
BMC Public Health; 2020 Dec; 20(1):1883. PubMed ID: 33287795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
